MedPath

Maxinovel Pty., Ltd.

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:9
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 1
9 (81.8%)
Phase 2
2 (18.2%)

A Study of MAX-40279combined With KN046 in Patients With Advanced / Metastatic Solid Tumors

Phase 1
Not yet recruiting
Conditions
Advanced / Metastatic Solid Tumors
First Posted Date
2022-06-21
Last Posted Date
2022-06-21
Lead Sponsor
Maxinovel Pty., Ltd.
Target Recruit Count
108
Registration Number
NCT05425602

A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction Cancer

Phase 2
Conditions
Gastroesophageal Junction Cancer
Gastric Cancer
Interventions
First Posted Date
2022-05-27
Last Posted Date
2022-06-02
Lead Sponsor
Maxinovel Pty., Ltd.
Target Recruit Count
30
Registration Number
NCT05395780
Locations
🇨🇳

Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jingsu, China

A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors

Phase 1
Conditions
Solid Tumor
Interventions
Drug: "MAX-40279-01" and "Toripalimab"
First Posted Date
2022-05-11
Last Posted Date
2022-05-11
Lead Sponsor
Maxinovel Pty., Ltd.
Target Recruit Count
28
Registration Number
NCT05369286
Locations
🇨🇳

Institute of The Sixth Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China

A Study to Evaluate the Safety of MAX-40070 in Healthy Subjects

Phase 1
Conditions
Alopecia Areata
Interventions
Drug: Placebo
First Posted Date
2022-01-19
Last Posted Date
2022-01-19
Lead Sponsor
Maxinovel Pty., Ltd.
Target Recruit Count
78
Registration Number
NCT05196711

MAX-10181 in Patients With Advanced Solid Tumor

Phase 1
Conditions
Solid Tumor
Interventions
First Posted Date
2022-01-19
Last Posted Date
2022-01-19
Lead Sponsor
Maxinovel Pty., Ltd.
Target Recruit Count
80
Registration Number
NCT05196360
Locations
🇨🇳

The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, China

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath